Nataliya Melnyk

6.6k citations

18 papers · 2.0k indexed · 1 hit paper · h-index 15

Co-authors: David G. Huntsman Janine Senz C. Blake Gilks Winnie Yang Jessica N. McAlpine Melissa K. McConechy Sohrab P. Shah Janice S. Kwon
Topics: Ovarian cancer diagnosis and treatment (5 papers)Endometrial and Cervical Cancer Treatments (3 papers)PI3K/AKT/mTOR signaling in cancer (3 papers)
Cited by: Obstetrics and Gynecology Reproductive Medicine Cancer Research
Journals: Nature Medicine PLoS ONE Molecular and Cellular Biology
Partner nations: Canada United States United Kingdom

In The Last Decade

Nataliya Melnyk

17 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A clinically applicable molecular-based classification for endometrial cancers

2015 622 citations Aline Talhouk, Melissa K. McConechy et al. British Journal of Cancer profile →

Peers

Countries citing papers authored by Nataliya Melnyk

Since Specialization

Citations

This map shows the geographic impact of Nataliya Melnyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nataliya Melnyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nataliya Melnyk more than expected).

Fields of papers citing papers by Nataliya Melnyk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nataliya Melnyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nataliya Melnyk. The network helps show where Nataliya Melnyk may publish in the future.

Co-authorship network of co-authors of Nataliya Melnyk

This figure shows the co-authorship network connecting the top 25 collaborators of Nataliya Melnyk. A scholar is included among the top collaborators of Nataliya Melnyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nataliya Melnyk. Nataliya Melnyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Albumin promotes the progression of fibroblasts through late G₁ into S-phase in the absence of growth factors 2020 ·Cell Cycle ·Sharmeen Uddin,Nataliya Melnyk,David A. Foster	5
2	Frequent NFIB-associated Gene Rearrangement in Adenoid Cystic Carcinoma of the Vulva 2016 ·International Journal of Gynecological Pathology ·Deyin Xing,(unknown),Nataliya Melnyk,Christina Isacson,Julie Ho,David G. Huntsman,C. Blake Gilks,Brigitte M. Ronnett,Hugo M. Horlings	24
3	A clinically applicable molecular-based classification for endometrial cancersbreakdown → 2015 ·British Journal of Cancer ·Aline Talhouk,Melissa K. McConechy,Samuel Leung,Hector Li-Chang,Janice S. Kwon,Nataliya Melnyk,Winnie Yang,Janine Senz,Niki Boyd,Anthony N. Karnezis,David G. Huntsman,C. Blake Gilks,Jessica N. McAlpine	622
4	Molecular characterization of a population-based series of endometrial stromal sarcomas in Kuwait 2014 ·Human Pathology ·Rola H. Ali,(unknown),Salah Al-Waheeb,(unknown),Waleed Al-Ali,Waleed Al-Jassar,Fahd Al‐Mulla,Nataliya Melnyk,David G. Huntsman,Cheng‐Han Lee	7
5	Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research 2013 ·PLoS ONE ·Michael S. Anglesio,Kimberly C. Wiegand,Nataliya Melnyk,Christine Chow,Clara Salamanca,Leah Prentice,Janine Senz,Winnie Yang,Monique A. Spillman,Dawn R. Cochrane,Karey Shumansky,Sohrab P. Shah,Steve E. Kalloger,David G. Huntsman	31
6	Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles 2013 ·Modern Pathology ·Melissa K. McConechy,Jiarui Ding,Janine Senz,Winnie Yang,Nataliya Melnyk,Alicia Tone,Leah Prentice,Kimberly C. Wiegand,Jessica N. McAlpine,Sohrab P. Shah,Cheng‐Han Lee,Paul J. Goodfellow,C. Blake Gilks,David G. Huntsman	186
7	Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research 2013 ·PLoS ONE ·Michael S. Anglesio,Kimberly C. Wiegand,Nataliya Melnyk,Christine Chow,Clara Salamanca,Leah Prentice,Janine Senz,Winnie Yang,Monique A. Spillman,Dawn R. Cochrane,Karey Shumansky,Sohrab P. Shah,Steve E. Kalloger,David G. Huntsman	197
8	Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors 2012 ·Modern Pathology ·(unknown),Farshad C. Azimi,Rola H. Ali,Cheng‐Han Lee,Blaise Clarke,Golnar Rasty,Patricia A. Shaw,Nataliya Melnyk,David G. Huntsman,Stéphane Laframboise,Marjan Rouzbahman	31
9	Copy Number Aberrations in Benign Serous Ovarian Tumors: A Case for Reclassification? 2011 ·Clinical Cancer Research ·Sally M. Hunter,Michael S. Anglesio,Raghwa Sharma,C. Blake Gilks,Nataliya Melnyk,Yoke-Eng Chiew,Anna DeFazio,Teri A. Longacre,David G. Huntsman,Kylie L. Gorringe,Ian Campbell	17
10	deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data 2011 ·PLoS Computational Biology ·Andrew McPherson,Fereydoun Hormozdiari,(unknown),(unknown),Gavin Ha,Mark Sun,Malachi Griffith,Alireza Heravi Moussavi,Janine Senz,Nataliya Melnyk,Marina Pacheco,Marco A. Marra,Martin Hirst,Torsten O. Nielsen,S. Cenk Şahinalp,David G. Huntsman,Sohrab P. Shah	325
11	Frequency of Known Gene Rearrangements in Endometrial Stromal Tumors 2011 ·The American Journal of Surgical Pathology ·Sarah Chiang,Rola H. Ali,Nataliya Melnyk,Jessica N. McAlpine,David G. Huntsman,C. Blake Gilks,Cheng‐Han Lee,Esther Oliva	93
12	ETV6-NTRK3–Mediated Breast Epithelial Cell Transformation Is Blocked by Targeting the IGF1R Signaling Pathway 2010 ·Cancer Research ·Cristina E. Tognon,Aruna M. Somasiri,Valentina Evdokimova,(unknown),(unknown),Nataliya Melnyk,Joan M. Carboni,Marco M. Gottardis,Calvin D. Roskelley,Michaël Pollak,Poul H. Sorensen	52
13	Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma 2010 ·Oncogene ·Susanna L. Cooke,Charlotte K.Y. Ng,Nataliya Melnyk,María J. García,Thomas J. Hardcastle,Jillian Temple,Simon P. Langdon,David Huntsman,James D. Brenton	126
14	HORMONAL CARCINOGENESIS OF THE OVARYAND ITS MODELING METHODS 2010 ·Clinical anatomy and operative surgery ·(unknown),Nataliya Melnyk,(unknown)	1
15	The Specificity of the FOXL2 c.402C>G Somatic Mutation: A Survey of Solid Tumors 2009 ·PLoS ONE ·Kasmintan A. Schrader,(unknown),Janine Senz,Alireza Heravi‐Moussavi,Nataliya Melnyk,Clara Salamanca,Sarah Maines‐Bandiera,Susanna L. Cooke,Peter C. K. Leung,James D. Brenton,C. Blake Gilks,John E. Monahan,David G. Huntsman	71
16	The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers 2007 ·Nature Medicine ·Liyong Zhang,Michael S. Anglesio,Maureen J. O’Sullivan,Fan Zhang,Ge Yang,Renu Sarao,Mai P. Nghiem,Shane J. F. Cronin,Hiromitsu Hara,Nataliya Melnyk,Liheng Li,Teiji Wada,Peter P. Liu,Jason E. Farrar,R.J. Arceci,Poul H. Sorensen,Josef Penninger	113
17	The Insulin-Like Growth Factor I Receptor Is Required for Akt Activation and Suppression of Anoikis in Cells Transformed by the ETV6-NTRK3 Chimeric Tyrosine Kinase 2006 ·Molecular and Cellular Biology ·Matthew J. Martin,Nataliya Melnyk,(unknown),Mary Bowden,Hon S. Leong,Thomas J. Podor,Martin Gleave,Poul H. Sorensen	57
18	Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney 2004 ·Human Molecular Genetics ·Michael S. Anglesio,Valentina Evdokimova,Nataliya Melnyk,Liyong Zhang,Conrad V. Fernandez,Paul E. Grundy,Stephen Leach,Marco A. Marra,Angela Brooks‐Wilson,Josef Penninger,Poul H. Sorensen	91

About Nataliya Melnyk

Nataliya Melnyk is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Molecular Biology, having authored 18 papers that have together received 2.0k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (5 papers), Endometrial and Cervical Cancer Treatments (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Obstetrics and Gynecology (738 citations), Reproductive Medicine (755 citations) and Cancer Research (523 citations). Nataliya Melnyk has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include David G. Huntsman, Janine Senz, C. Blake Gilks, Winnie Yang, Jessica N. McAlpine, Melissa K. McConechy, Sohrab P. Shah, Janice S. Kwon, Samuel Leung and Hector Li-Chang. Their work appears in journals such as Nature Medicine, PLoS ONE and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact